Cumulus Oncology

Cumulus Oncology is a company creation studio specialising in oncology drug discovery and development.

The company identifies and sources novel cancer therapeutic assets from academic and commercial organisations, funds them, and incorporates them into newly created spin-out biotechs.

Cumulus provides scientific expertise, early-stage capital, and development management to each spin-out, applying AI and machine learning to asset prioritisation and target selection.

Portfolio companies include Nodus Oncology, focused on DNA damage response, and GIO Therapeutics.